Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Icadom | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Regular bronchial clearance is essential in patients with cystic fibrosis for their bronchial health. SIMEOX® (Physio-Assist, Aix en Provence, France) is an innovative medical device for the drainage of the bronchial tree. By changing the rheological properties of mucus, SIMEOX® helps to mobilize secretions and assists their transport to the upper airways. This technology is based on fundamental research on bronchial mucus rheology. At the present time, SIMEOX® device is mainly used over a short period at the time or after an exacerbation in healthcare structures (hospitals, physiotherapy practices, postcare, and rehabilitation units, etc…). The clinical effects observed in the short term encourages long-term autonomous use by the patients themselves. The overall objective of this study is to evaluate the efficiency and acceptability of SIMEOX® used at home by the patient himself for bronchial clearance in patients with cystic fibrosis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SIMEOX | Experimental | Use the device for 3 months in addition to usual care |
|
| Control | No Intervention | Usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SIMEOX | Device | Use without obligation, in autonomous and at home of the bronchial clearance device: SIMEOX |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pulmonary static hyperinflation assessed by residual volume | Relative variation in Pulmonary residual volume in the SIMEOX® treated group versus control group. | Change from baseline at 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Use assessed by the duration of use of SIMEOX® device | Assess the duration of uses of the device SIMEOX by the patient in the SIMEOX® treated group to assess the use by patient of the device. | During 3 months of use |
| Inspiratory capacity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Boubou Camara, MD | CHUGA | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Grenoble University Hospital : pneumo-pediatric department | Grenoble | 38043 | France | |||
| Grenoble University-Affiliated Hospital : Pneumology department |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Prospective, randomized, controlled, multicenter trial
Not provided
Not provided
Not provided
Not provided
Relative variation of Inspiratory capacity in liter in the SIMEOX® treated group versus control group
| Change from baseline at 3 months |
| Residual functional capacity (RFC) | Relative variation of Residual functional capacity (RFC) in liter in the SIMEOX® treated group versus control group | Change from baseline at 3 months |
| Total lung capacity (TLC) | Relative variation of Total lung capacity (TLC) in liter in the SIMEOX® treated group versus control group | Change from baseline at 3 months |
| Grenoble |
| 38043 |
| France |
| Montpellier Hospital Center | Montpellier | 34000 | France |
| Nice University-Affiliated Hospital : Pneumology department | Nice | 06002 | France |
| Nice University-Affiliated Hospital : Pneumo-pediatric department | Nice | 06200 | France |
| D030342 |
| Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |